Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Rosuvastatin Preloading in STEMI (HEROS-PCI)
NCT06924684Phase 2Active, not recruiting
- Sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in ST elevation myocardial infarction (STEMI), sponsored by Sheikh Zayed Federal Postgraduate Medical Institute. Started Dec 2024; status: active, not recruiting.
02
Drugs
rosuvastatin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06924684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06924684.